A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.
Ann. Oncol., Jul;22(7):1608-13 (2011)
(90)Y-ibritumomab tiuxetan followed by reduced-intensity conditioning and allo-SCT in patients with advanced follicular lymphoma.
Bone Marrow Transplant., Dec;46(12):1503-9 (2011)
Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid-immunoglobulin complexes in humans.
J. Clin. Invest., Apr;121(4):1574-84 (2011)
Combined CD4 T-cell and antibody response to human minor histocompatibility antigen DBY after allogeneic stem-cell transplantation.
Transplantation., Aug;92(3):359-65 (2011)
Cord colitis syndrome in cord-blood stem-cell transplantation.
N. Engl. J. Med., Sep;365(9):815-24 (2011)
Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.
Blood., Dec;118(25):6691-7 (2011)
Reduced-intensity conditioning stem cell transplantation: comparison of double umbilical cord blood and unrelated donor grafts.
Biol. Blood Marrow Transplant., May;18(5):805-12 (2012)
Multicenter validation study of a transplantation-specific cytogenetics grouping scheme for patients with myelodysplastic syndromes.
Bone Marrow Transplant., May;45(5):877-85 (2010)
Finding the right academic job.
Hematology Am Soc Hematol Educ Program., 729-33 (2009)
Reduced-intensity conditioning hematopoietic stem cell transplantation in patients over 60 years: hematologic malignancy outcomes are not impaired in advanced age.
Biol. Blood Marrow Transplant., Jun;16(6):792-800 (2010)
Serologic markers of effective tumor immunity against chronic lymphocytic leukemia include nonmutated B-cell antigens.
Cancer Res., Feb;70(4):1344-55 (2010)
Outcome of allo-SCT for women with MDS or AML occurring after breast cancer therapy.
Bone Marrow Transplant., Nov;45(11):1611-7 (2010)
Altered regulatory T cell homeostasis in patients with CD4+ lymphopenia following allogeneic hematopoietic stem cell transplantation.
J. Clin. Invest., May;120(5):1479-93 (2010)
Graft-versus-leukemia antigen CML66 elicits coordinated B-cell and T-cell immunity after donor lymphocyte infusion.
Clin. Cancer Res., May;16(10):2729-39 (2010)
Iron overload in patients with acute leukemia or MDS undergoing myeloablative stem cell transplantation.
Biol. Blood Marrow Transplant., Jun;17(6):852-60 (2011)
Syngeneic donor hematopoietic stem cell transplantation is associated with high rates of engraftment syndrome.
Biol. Blood Marrow Transplant., Mar;17(3):421-8 (2011)
Seroprotective titers against 2009 H1N1 influenza A virus after vaccination in allogeneic hematopoietic stem cell transplantation recipients.
Biol. Blood Marrow Transplant., Mar;17(3):434-8 (2011)
Invasive fungal disease after remote inoculation in transplant recipients.
Clin. Infect. Dis., Jan;52(1):e7-10 (2011)
Use of matched unrelated donors compared with matched related donors is associated with lower relapse and superior progression-free survival after reduced-intensity conditioning hematopoietic stem cell transplantation.
Biol. Blood Marrow Transplant., Aug;17(8):1196-204 (2011)
A prognostic score for patients with acute leukemia or myelodysplastic syndromes undergoing allogeneic stem cell transplantation.
Biol. Blood Marrow Transplant., Jan;14(1):28-35 (2008)